The Top 10 Contract Research Organizations: Positioning, Performance and SWOT Analyses Now Available at ReportsandReports
Cost containment and regulatory pressures within the pharma industry are driving R&D outsourcing across the globe. Clinical obstacles to approval have become more significant due to the growing availability of existing generic treatments, and the trend to adopt Health Economics Outcomes Research (HEOR) assessments is increasing the complexity of clinical research.
View full press release